Shu-Ping Yang
17Patents
5h-index
33Co-inventors
62Inventor score
Filing activity: Mar 28, 2003 → Dec 18, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7094528B2 | Magnetic enzyme detection techniques | Physics | 9 | Expired |
| US7786176B2 | Vaginal treatment composition containing xylitol | Human Necessities | 9 | Active |
| US7258878B2 | Anti-microbial composition and methods of use thereof | Human Necessities | 9 | Expired |
| US10555942B2 | Emetine compounds for treatment and prevention of flavivirus infection | Emerging Cross-Sectional Technologies | 7 | Active |
| US7619008B2 | Xylitol for treatment of vaginal infections | Human Necessities | 6 | Active |
| US7713252B2 | Therapeutic article including a personal care composition and methods of making the therapeutic article | Human Necessities | 5 | Expired |
| US7514230B2 | Detection of trichomonas | Human Necessities | 2 | Expired |
| US7238677B2 | Prevention of urogenital infections | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7189700B2 | Anti-chrondrosarcoma compounds | Human Necessities | 1 | Expired |
| US8399012B2 | Degradable therapeutic delivery device | Chemistry; Metallurgy | 0 | Active |
| US8784868B2 | Degradable therapeutic delivery device | Chemistry; Metallurgy | 0 | Active |
| US7795225B2 | Anti-chrondrosarcoma compounds | Human Necessities | 0 | Active |
| US9657257B2 | Colorant neutralizer | Chemistry; Metallurgy | 0 | Active |
| US11207315B2 | Emetine compounds for treatment and prevention of flavivirus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US7276486B2 | Compositions for vaginal treatment | Human Necessities | 0 | Expired |
| US10428129B2 | Recombinant protein | Chemistry; Metallurgy | 0 | Active |
| US7658947B2 | Thermo-gelling composition | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.